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Abstract
Background: While discussion continues over the future implementation of lung can-
cer screening, low participation from higher risk groups could limit the effectiveness of 
any national screening programme.
Objectives: To compare smokers’ beliefs about lung cancer screening with those of 
former and never smokers within a low socioeconomic status (SES) sample, to explore 
the views of lower SES smokers and ex- smokers in- depth, and to provide insights into 
effective engagement strategies.
Design, setting and participants: Using proactive, community- based recruitment 
methods, we surveyed 175 individuals from socioeconomically deprived communities 
with high smoking prevalence and subsequently interviewed 21 smokers and ex- 
smokers. Participants were approached in community settings or responded to a mail- 
out from their housing association.
Results: Interviewees were supportive of screening in principle, but many were doubt-
ful about its ability to deliver long- term survival benefit for their generation of “heavy 
smokers.” Lung cancer was perceived as an uncontrollable disease, and the survey 
data showed that fatalism, worry and perceived risk of lung cancer were particularly 
high among smokers compared with non- smokers. Perceived blame and stigma around 
lung cancer as a self- inflicted smokers’ disease were implicated by interviewees as 
important social deterrents of screening participation. The belief that lungs are not a 
treatable organ appeared to be a common lay explanation for poor survival and under-
mined the potential value of screening.
Conclusions: Attitudes towards screening among this high- risk group are complex. 
Invitation strategies need to be carefully devised to achieve equitable participation in 
screening.
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1  | INTRODUCTION
In 2011, there were over 35 000 deaths from lung cancer in the UK, 
representing 22% of total cancer mortality.1 Early stage at diagnosis is 
the strongest predictor of survival2 but only 15% of patients are diag-
nosed at Stage 1,3 and the diagnosis is often incidental.4 One promising 
strategy for improving outcomes is to screen for early stage disease in 
high- risk smokers and ex- smokers using low- dose computed tomogra-
phy (LDCT). The National Lung Screening Trial (NLST) found a 20% rela-
tive risk reduction in lung cancer mortality following three annual LDCT 
screens compared with chest X- ray,5 and the United States Preventive 
Service Task Force (USPSTF) recommend screening in conjunction with 
smoking cessation counselling.6 However, a favourable harm–benefit 
screening ratio depends on engaging those at high risk with screening.7,8
Individual risk prediction is becoming increasingly sophisticated 
and the science of identifying eligible screening candidates ever more 
precise.9 Smoking is the key risk factor for lung cancer, accounting 
for 86% of diagnoses made within the United Kingdom;10 with other 
risk factors including occupational exposures,11 respiratory disease12 
and a family history of lung cancer.13 Rates of smoking in the UK are 
highest in socioeconomically deprived areas, where lung cancer inci-
dence and survival are worse.14 Lower socioeconomic status (SES) 
may amplify risk due to younger age of starting smoking, and greater 
tobacco smoke inhalation, nicotine dependence, second- hand smoke 
exposure and difficulty quitting.15–18 Other risk factors, such as a his-
tory of pneumonia, also increase with measures of deprivation.19 In 
the UK Lung Screening Trial (UKLS), the number of participants regis-
tering a high score on the Liverpool Lung Project (LLP) risk prediction 
model ranged from 8% to 18% from the least to most socioeconomi-
cally deprived quintiles.20
Smokers from deprived communities are therefore an import-
ant group to engage with screening, but participation in trials has 
been skewed towards former smokers and the better educated.20,21 
Compared with an eligible population cohort (a subsample of respon-
dents to the US Census Department’s Tobacco Use Supplement), 
NLST participants were younger, had more years of education and 
were more likely to be former (than current) smokers.22 Surveys car-
ried out away from clinical settings in the United States have begun to 
identify attitudes that might discourage smokers’ participation. One 
survey found smokers were less likely to perceive survival benefit 
from lung cancer screening or believe they would undergo surgery for 
a screen- detected cancer.23 In an ethnically diverse sample, fatalism, 
concern about radiation and anxiety about having a CT scan predicted 
lower screening intentions.24
Three studies25–27 specifically investigated the attitudes of those 
declining screening offered in the trial context, although the response 
rate in this group (of all those invited) is usually <10%. Non- participants 
who responded to a follow- up survey (n=97) in the Dutch–Belgian tri-
al NELSON were found to perceive screening as too much effort or 
unnecessary due to a lack of respiratory symptoms.25 In the UK Lung 
Screening Trial (UKLS), a survey of non- participants (n=748) found a 
small proportion of smokers to report emotional barriers to participa-
tion, but practical barriers were most commonly cited.26 A qualitative 
study of patients (n=24) declining participation in a UK screening trial 
(Lung- SEARCH) for COPD patients identified four types of attitudes 
explaining reluctance to participate: worry, fatalism, avoidance and 
believing oneself too old to benefit.27
There are no data from the United Kingdom on beliefs about 
lung cancer screening among individuals from socioeconomically 
deprived communities with high smoking prevalence, a group less 
likely to engage in research carried out through traditional channels 
and for whom proactive recruitment methods may be better suited. 
The effectiveness of any lung cancer screening programme depends, 
in part, upon uptake and any inequalities in participation ultimately 
have the potential to exacerbate inequalities in lung cancer survival. 
Understanding why screening participation is low among this high- 
risk group would contribute to the development of evidence- based 
engagement strategies and invitation materials to ensure the reach 
of any future screening programme is equitable. Therefore, this study 
investigated attitudes towards lung cancer screening within lower SES 
communities with the aim of (i) understanding how attitudes might 
differ by smoking status, (ii) exploring the attitudes of smokers and ex- 
smokers in- depth and (iii) identifying factors that could be targeted in 
screening communication strategies.
2  | METHOD
2.1 | Mixed methods design
Study one used a quantitative survey design to compare smokers’ 
beliefs about lung cancer screening with those of former and never 
smokers, recruited from lower SES communities. Study two inter-
viewed a subset of survey participants to explore the views of smok-
ers and former smokers in- depth, to investigate factors that might be 
important for screening participation. Ethics approval was granted by 
the UCL research ethics committee (reference: 5210/001).
2.2 | Recruitment methods
Proactive, community- based strategies were used to recruit individuals 
from lower SES communities, with the aim of involving individuals in 
research who might be less likely to participate in research carried out 
using traditional recruitment methods, central to understanding non- 
participation. Individual people leading activities, organizations, venues 
or development work in socioeconomically deprived areas were iden-
tified from online searches, council listings and literature displayed in 
community centres. Selections were made on the basis that they (i) had 
networks with relevant local groups; (ii) provided free support and out-
reach services to those living in deprived conditions; (iii) worked within 
a manual workplace where smoking rates are  higher; (iv) provided social 
housing; and (v) were not providing a health service. A researcher (SLQ) 
met with interested community leaders to seek advice on recruitment 
approaches and to access their networks to identify other recruitment 
opportunities. The recruitment approach was two- pronged for both 
studies: (i) participants were approached directly in community settings 
by SLQ and (ii) two housing associations mailed the survey to tenants. 
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Recruitment settings ranged from organized community- based services 
(e.g. free drop- in advice service for housing issues) to locations with a 
high footfall (e.g. bus station and markets).
2.3 | Survey Study one
2.3.1 | Participants
Adults aged ≥40 years were eligible. Adults younger than the 
screening- eligible age (aged 55–80 years6) were included because 
they are approaching eligibility and are representative of the gener-
ation who would comprise the first screening cohort in the United 
Kingdom, pending recommendation of screening. Never smokers 
were included for comparative purposes, because former smokers 
were once current smokers and may share characteristics associated 
with smoking uptake. The inclusion of never smokers also intended to 
provide insight into the wider social context within which screening 
would be considered.
Participants were recruited from lower SES communities in 
Central and South-East London. As an example, in one of the South-
East London boroughs, population statistics indicate that 86% of res-
idents are classified within the two most deprived Index of Multiple 
Deprivation (IMD) quintiles.28 Smoking prevalence is highest within 
these quintiles: 33% of men and 26% of women smoke in the most 
deprived IMD quintile, and 26% of men and 20% of women smoke in 
the second most deprived IMD quintile.29
2.3.2 | Measures
A survey was constructed using items adapted from existing meas-
ures of cancer beliefs (for lung and other types24,30–34), and original 
items were developed based on the findings of an existing qualitative 
study.27 The inclusion of items was therefore driven by the available 
literature rather than a specific theoretical model.
The survey began with a brief description of screening, which 
explained that the test aimed to find lung cancer at an early stage 
when there was a better chance of cure, and that it used a “type of 
X- ray called a CT scan.” Participants were then asked to rate their 
agreement (strongly disagree/disagree/agree/strongly agree/don’t 
know) with each item. Items covered the following topics in relation to 
lung cancer or lung cancer screening: smoking, worry and avoidance, 
perceived benefit, lung cancer outcomes, perceived risk, practical bar-
riers and the need for screening without symptoms.
Smoking data were also collected, including self- reported smoking 
status, age started daily smoking and maximum number of cigarettes 
smoked daily (to calculate pack- year history), number of quit attempts 
lasting ≥3 months, age of quitting and quit confidence (on a scale of 0 
to 10). Demographic characteristics included sex, age, marital status, 
ethnicity, education, postcode (to calculate IMD rank35) and employ-
ment status.
The survey was paper- based and designed to be self- completed. 
SLQ assisted participants with completing the survey if they had diffi-
culty or preferred it to be read aloud.
2.3.3 | Analyses
Univariate chi- square analyses and Fisher’s exact tests were car-
ried out to explore associations between smoking status and item 
agreement. Multivariate analyses were not carried out because there 
were too few cases to provide adequate statistical power. For the 
same reason, we did not lower the statistical significance threshold 
to adjust for multiple testing, but report the respective significance 
thresholds.
2.4 | Interview Study two
2.4.1 | Participants
After each participant had completed the survey, the researcher 
screened their responses to purposively sample a subgroup of inter-
viewees who had indicated they were current or former smokers, and 
from lower SES backgrounds (as indicated by an area- based measure 
of deprivation or their education level). Arrangements for interview 
were made immediately with participants who indicated they were 
willing to be interviewed, to minimize attrition. Therefore, recruitment 
for interviewing and the survey began at the same time and interviews 
ceased when no new information was gleaned from the data.
2.4.2 | Measures
Semi- structured telephone interviews were carried out, during which 
participants were asked open- ended questions on three main top-
ics: (i) benefits/barriers to screening (e.g. “Can you talk me through 
your reasons for going/not going [to screening]?”), (ii) the preferred 
approach for screening invitations (e.g. “Often, letters from the doc-
tor point out that the person is a smoker. How do you feel about 
that?”) and (iii) attitudes towards provision of smoking cessation sup-
port (e.g. “Smokers may also be asked if they would like advice or help 
with stopping smoking at their appointment. How do you feel about 
that?”). At the start of the interview, the same brief explanation of 
screening was given as in Study one, but participants were also asked 
to imagine they had received a screening invitation from their GP.
2.4.3 | Analyses
Transcripts were analysed using an inductive approach to the-
matic analysis with NVivo qualitative data analysis software (QSR 
International Pty Ltd. Version 10, 2012). Familiarization with the 
data began during the interviews and continued through repeated 
reading of the transcripts. Data were first coded openly, with mini-
mal interpretation. Themes and sub- themes were then interpreted 
and developed into a framework. Inclusion of themes depended on 
their frequency and contribution to the research question, that is fac-
tors that may be important when communicating a screening offer. 
A second researcher (LAVM) read ten randomly selected transcripts 
independently, to cross- check the framework, and any disagreements 
were resolved through discussion and revisiting the transcripts.
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3  | RESULTS
3.1 | Sample characteristics
Most participants were approached directly in the community context 
by SLQ (n=14 interviewees; n=100 questionnaire respondents). The 
remaining number responded to a questionnaire mail- out from two 
housing associations (n=7 interviewees; n=75 respondents). Around 
three- quarters of individuals approached in person completed the 
survey and the majority of eligible participants (>90%) subsequently 
contacted for interview took part. The response rate for mailed sur-
veys was very low (12%). Post-hoc analyses showed that participants 
recruited in- person were more frequently younger and current smok-
ers (P<.01) and had a higher level of education (P<.05) than those who 
responded to the mail- outs. There were no differences by deprivation, 
sex, ethnicity or marital status.
In total, 175 participants completed the survey. Occasional smok-
ers (n=7) and those reporting a diagnosis of lung cancer (n=5) were 
excluded from analyses. Of the remaining 163 participants, 28% iden-
tified as current smokers, 44% were ex- smokers and 29% had never 
smoked. Of these, nine smokers and 12 ex- smokers (N=21) were inter-
viewed (see Table 1).
Men and women were evenly represented. Samples had a similar 
mean age (interviews: 62 years; survey: 64 years) and were mostly white 
(91% and 79%), unmarried or widowed (86% and 66%) and retired (both 
52%). The majority were from lower SES backgrounds, as indexed by 
an area- based measure of deprivation (most deprived IMD quintile: 
76% and 51%), and education (no formal qualifications/left school age 
≤15 years: 71% and 55%). The higher proportion of lower SES inter-
viewees compared with survey respondents was intentional and part of 
the purposive sampling frame. Many participants reported that they had 
experience of lung cancer through a “close other” (48% and 37%).
With regard to smoking history, on average, current and former 
smokers had begun smoking in their mid- teens (M: 14.5; SD: 6.5 and 
M: 16.7; SD: 5.4) and accrued a high pack- year history (M: 67.6; range: 
6–285 and M: 51.6; range: 0.5–285; eligibility for screening is ≥30 
pack- years6). Current smokers were largely not confident in their abil-
ity to quit (mean rating of 4.4 out of 10; SD: 4.5 and M: 4.9; SD: 3.5).
3.2 | Univariate analysis of survey data
The key findings are described here, but all univariate results are 
shown in Table 2 and Table S1.
3.3 | Beliefs about smoking and lung 
cancer screening
Current smokers were most likely to agree with some of the beliefs 
about smoking which conflict with participating in or benefiting from 
screening. Twenty per cent (n=9) believed they had “smoked too long 
to benefit” (vs 4%, n=3 of former smokers; P<.05) and almost a third 
(30%, n=13) agreed that “if the CT scan is negative you can continue 
TABLE  1 Demographic and smoking characteristics
Interview (n=21) Survey (n=163)
Sex, % (n)
Male 52.4 (11) 41.1 (67)
Female 47.6 (10) 58.9 (96)
Age group, % (n)
41–49 4.8 (1) 5.5 (9)
50–59 33.3 (7) 24.5 (40)
60–69 52.3 (11) 33.1 (54)
70–79 9.5 (2) 27.6 (45)
80+ 0 (0) 3.1 (5)
Marital status, % (n)
Married/Civil partnership/
Cohabiting
14.3 (3) 33.7 (55)
Single/Divorced/Widowed 85.7 (18) 66.3 (108)
Ethnicity, % (n)
White British/Irish/White 
other
90.5 (19) 78.5 (128)
Not White 9.5 (2) 19.6 (32)
Highest level of education, % (n)
Left school at or before age 
15/no formal qualifications
71.4 (15) 54.6 (89)
CSEs/O- levels/ONC/BTEC/
Other
19.0 (4) 23.3 (38)
A- levels/Higher education 
qualification below degree
4.8 (1) 9.2 (15)
University degree 4.8 (1) 12.9 (21)
IMD rank quintile (rank range), % (n)
Quintile 1 (1–6496) most 
deprived
76.2 (16) 50.9 (83)
Quintile 2 (6497–12993) 14.3 (3) 26.4 (43)
Quintile 3 (12994–19489) 4.8 (1) 1.2 (2)
Quintile 4 (19490–25986) 0 (0) 3.1 (5)
Quintile 5 (25987–32482) 
least deprived
0 (0) 0.6 (1)
Employment status, % (n)
Employed full time/Part time/
Self employed
23.8 (5) 28.8 (47)
Unemployed 14.3 (3) 8.6 (14)
Full- time homemaker/Carer 0 (0) 4.3 (7)
Retired 52.4 (11) 52.1 (85)
Disabled or too ill to work 9.5 (2) 5.5 (9)
Studying 0 (0) 0.6 (1)
Smoking status, % (n)
Current smoker 42.9 (9) 27.6 (45)
Former smoker 57.1 (12) 43.6 (71)
Never smoker 0 (0) 28.8 (47)
Experience of lung cancer, % (n)
Yes (someone close or prefer 
not to say who)
47.6 (10) 36.9 (60)
None 47.6 (10) 62.0 (101)
Smoking history, range (mean, SD)
Mean age started smoking 
daily (≥1 cigarette or roll up)
6–39 (14.5, 6.5) 6–40 (16.7, 5.4)
Number of times stopped 
smoking (≥3 months)
0–6 (1.1, 1.7) 0–10 (1.1, 1.9)
Age stopped smoking (former 
smokers only)
38–66 (54.8, 9.2) 20–82 (50.1, 13.4)
Pack years 6–285 (67.6, 57.5) 0.5–285 (51.6, 
43.5)
Quit confidence rating of 10 
(current smokers only)
0–10 (4.4, 4.5) 0–10 (4.9, 3.5)
N and % totals may not sum due to missing data.
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to smoke without worrying about lung cancer” (vs 6%, n=4 of former 
smokers and 4%, n=2 of never smokers; P<.001; see Table 2).
3.4 | Perceived risk of lung cancer
More current smokers perceived their risk of getting lung cancer as 
high over “the next few years” (48%, n=21) than former (10%, n=7) 
and never smokers (7%, n=3; P<.001), and over a third (36%, n=16) 
agreed their lifetime risk “is higher than other smokers.” Forty- four 
per cent (n=20) felt “I will get lung cancer sometime during my life” 
(vs 10%, n=7 and 17%, n=8, respectively, P<.001). Eighteen per cent 
(n=8) of smokers thought they “may already have lung cancer” but the 
proportion agreeing was not significantly different to former or never 
smokers (see Table 2).
3.5 | Worry about lung cancer
Three- quarters (75%, n=33) of current smokers agreed they “often wor-
ry” about getting lung cancer (vs 25%, n=17 and 27%, n=12 of former 
and never smokers; P<.001), and fewer (55%, n=24) believed “a clear CT 
scan would stop me worrying” (vs 81%, n=54 and 68%, n=30; P<.05). 
However, smokers were no more likely to agree worry would deter 
them from screening or that they were “very scared of getting lung can-
cer”, items endorsed across smoking groups (see Table 2).
3.6 | Lung cancer outcomes
Fewer than half (n=71) of the sample agreed “people with lung can-
cer can expect to continue with their normal activities” and over a 
fifth (22%, n=35) thought “treatment is worse than the lung cancer 
itself.” Smokers were most pessimistic about survival, with almost half 
agreeing lung cancer is “a death sentence” (48%, n=21 vs 13%, n=9 of 
former smokers and 11%, n=5 of never smokers, P<.001; see Table 2). 
However, there was no significant association with smoking status for 
agreeing that “lung cancer can often be cured.”
3.7 | Online supplementary results
Additional results on beliefs about perceived benefits of screening, 
avoidance, symptoms, and practical barriers are provided in Table 
S1 in the interests of space. Briefly, there were almost no significant 
associations with smoking status. Overall, endorsement of perceived 
benefits was high (>64%), avoidant beliefs were held by around one- 
fifth (18%–25%) and few endorsed practical barriers.
TABLE  2 Frequencies, chi- square analyses and Fisher’s exact tests for agreement with each belief item by smoking status (Survey Study 
one)
Smoking status % (n) agree
Overall 
(n=163)
Current 
(n=45)
Former 
(n=71)
Never 
(n=47) Sig.
Smoking
The people doing the lung cancer screening could be rude to smokers 13.1 (21) 20.5 (9) 8.7 (6) 12.8 (6) .489*
There is no point going for lung cancer screening while you are still smoking 10.7 (17) 2.3 (1) 14.5 (10) 13.0 (6) .046**
If the CT scan is negative, you can continue to smoke without worrying about lung 
cancer
12.0 (19) 29.5 (13) 5.8 (4) 4.4 (2) <.001**
I have smoked too long to benefit from lung cancer screening 10.3 (12) 20.0 (9) 4.3 (3) – .020**
Perceived risk
My personal risk of getting lung cancer during my lifetime is higher than other 
smokers
– 35.6 (16) – – –
I would have got lung cancer by now if I was going to 8.4 (13) 9.1 (4) 5.9 (4) 11.9 (5) .505**
I think I have a high chance of getting lung cancer in the next few years 19.5 (31) 47.7 (21) 10.1 (7) 6.5 (3) <.001**
I think I may already have lung cancer 8.2 (13) 17.8 (8) 4.3 (3) 4.5 (2) .053**
There’s no risk of getting lung cancer if you only smoke for a few years 5.0 (8) 4.4 (2) 7.2 (5) 2.2 (1) .534**
I feel I will get lung cancer sometime during my life 21.7 (35) 44.4 (20) 10.1 (7) 17.0 (8) <.001**
Once you stop smoking you are no longer at risk of lung cancer 8.8 (14) 8.9 (4) 11.6 (8) 4.4 (2) .264**
Worry
A clear CT scan would stop me worrying about lung cancer 69.7 (108) 54.5 (24) 80.6 (54) 68.2 (30) .023*
I often worry about my chance of getting lung cancer 38.0 (62) 75.0 (33) 24.6 (17) 26.7 (12) <.001**
I’d be too worried about lung cancer to have a lung cancer screening test 11.0 (18) 13.3 (6) 11.3 (8) 8.5 (4) .095**
I’m very scared of getting lung cancer 57.8 (93) 60.0 (27) 54.3 (38) 60.9 (28) .426**
Lung cancer outcomes
If I ever got lung cancer, I could be cured*** 38.8 (47) 28.0 (7) 36.8 (21) 48.7 (19) .125**
A diagnosis of lung cancer is a death sentence 22.0 (35) 47.7 (21) 13.0 (9) 10.9 (5) <.001*
Lung cancer can often be cured 46.3 (74) 40.9 (18) 50.7 (35) 44.7 (21) .498*
These days many people with lung cancer can expect to continue with their normal 
activities and responsibilities
44.9 (71) 39.5 (17) 54.3 (38) 35.6 (16) .085*
Most lung cancer treatment is worse than lung cancer itself 21.6 (35) 20.5 (9) 19.7 (14) 25.5 (12) .713*
*Chi- square analyses, **Fisher’s exact test. ***n=122.
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3.8 | Thematic analysis of interview data
Themes comprise two categories: the first encompasses general 
attitudes to lung cancer and the second concerns screening- specific 
attitudes. Short illustrative quotes are included in the text and longer 
quotes in Tables 3 and 4. Reference codes represent participant num-
ber (P), sex (F/M), smoking status (X/S = ex- smoker/smoker) and age.
3.9 | General attitudes
3.9.1 | Smoking: history, stigma and identity
Participants often explained or justified their smoking history, with 
many expressing “regret” and “guilt.” Current smokers in particular 
emphasized the difficulties of stopping, feeling “trapped” by addiction, 
and their attempts at cutting down. Some pointed out that when their 
generation began smoking, it was seen as “glamorous” and the risks 
were not well publicized.
Smoking was commonly described as a “stigmatized” and “taboo” 
behaviour, for which smokers had been “singled out” and “picked on.” 
Current smokers especially felt health professionals blamed them for 
their ill health and treated them unfairly, worrying that “you ain’t gon-
na get the proper diagnosis” (P3, M, S, 57). This was especially true of 
interviewees who emphasized smoking as part of their identity (“it’s a 
working class man’s thing,” P5, M, S, 56) and attempted to normalize 
the habit as something going on “since Robinson Crusoe” (P5, M, S, 56). 
Tellingly, the same participant added: “if they could give me something 
to stop me smoking, I’d take it straight away” (P5, M, S, 56) (see Table 3).
3.9.2 | Uncontrollable disease: risk, 
survival and treatment
Lung cancer was described as a “killer” disease, which is “aggressive” 
and a “painful way to go” (P9, M, X, 50) by both current and former 
smokers. The vital nature of lungs was implicated in poor survival with 
some questioning how treatment is possible given that “you can’t live 
without your lungs” (P9, M, X, 50). There was concern that treatment 
is ineffective and detrimental to quality of life. Some participants 
explained they would decline treatment, perceiving screening as some-
thing which “can never give you a new pair of lungs” (P1, M, X, 54).
Regardless of smoking status, many were concerned that there was 
little they could do to reduce their high risk of lung cancer, because of 
their smoking history. Some worried they may already have it: “you’ll 
always be worried if you’ve been a heavy smoker” (P13, F, X, 66). To 
compound this lack of control, risk was perceived as unpredictable. 
Interviewees cited the fact that a non- smoker can get lung cancer 
even if “they’ve never put a fag in their mouth” (P5, M, S, 56), and 
that “a lot of people smoke and still live to a ripe old age” (P16, F, X, 
67). Suggestions of other risk factors further reduced perceived con-
trol, including genetics, pollution, asbestos, poor housing, workplace 
exposures, stress and “cancer- grown foods” (P9, M, X, 50). Not smok-
ing was therefore not necessarily perceived as protective and many 
attributed their risk to chance. A minority underplayed smoking’s role 
in lung cancer risk as something that “doesn’t help” (P7, F, X, 57), or “a 
load of old toffee” (P5, M, S, 56) (see Table 3).
3.9.3 | Life circumstances: poor health, life 
experiences and addiction
Poor health and comorbidities were commonplace among participants’ 
family and friends, which included other cancers, smoking- related dis-
eases (especially COPD) and chronic diseases (e.g. diabetes). Vicarious 
experiences of others’ suffering with lung cancer were commonly ref-
erenced in relation to screening attitudes. Difficult life circumstances 
beyond health were also mentioned and implicated by some in a pes-
simistic outlook on life. Some interviewees alluded to their struggles 
with other addictions (see Table 3).
3.10 | Screening- specific attitudes
3.10.1 | Support for screening: early detection, 
reassurance and preparation before death
Participants were positive in principle about screening, and several 
indicated that they would participate; often because they perceived 
benefit in knowing whether they have lung cancer. Early detection 
was most commonly cited with regard to “less major treatments” (P1, 
M, X, 54), “better chance of cure” (P14, M, X, 73) and leading “a normal 
life for longer” (P9, M, X, 50), but notably more frequently by for-
mer smokers than current smokers. Furthermore, the language used 
to convey early detection principles was typically cautious about the 
ability to survive lung cancer in the long- term. Some appeared to pay 
“lip service” to the idea without real conviction, doubting the benefits: 
“whether that’s true, I’m not too sure” (P7, F, X, 57). Instead, some 
participants perceived the benefit of early detection to be “halting the 
growth” (P23, M, X, 66) until a cure became available, indicating a lack 
of awareness that early stage treatment can be curative.
Some participants welcomed the potential for reassurance that 
that they did not have lung cancer and motivation to stop smoking if 
given a “clean slate.” Others saw screening as an opportunity to pre-
pare family and personal affairs before they died. The importance of 
family was also apparent in the reasoning that “everyone wants to be 
around for their families” (P13, F, X, 66). One smoker began the inter-
view resolutely against screening, but thought differently when con-
sidering his grandchildren (see Table 4).
3.10.2 | Fear: diagnosis, hospitals, getting 
sick and death
Fear of diagnosis was commonly suggested as a deterrent to screen-
ing due to the expectation of a positive result, particularly for current 
smokers. For some, the decision to attend was interpreted as a deci-
sion to “find out” (P4, F, X, 58) about their lung cancer. This fear also 
appeared to originate from concerns around the whole care pathway, 
including getting sick, hospitals as a slippery slope from which the sick 
do not return and ultimately death.
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Some participants explained how receiving the invitation 
would frighten them, describing responses such as feeling “hor-
rified,” “panic” and “I would never stop worrying until I get the 
result” (P16, F, X, 67). Participants were not concerned about the 
CT scan, which was generally regarded as “only like taking a pic-
ture of your insides” (P7, F, X, 57). The exception was one partici-
pant concerned about radiation. Following a previous CT scan, he 
believed he “was radioactive for the rest of my life” (P1, M, X, 54) 
(see Table 4).
3.10.3 | Avoidance: rather not know and wait 
until sick
Not wanting to know was described as a reason to avoid screening, 
especially for current smokers, although most interviewees also 
said they would participate. Attending lung cancer screening was 
likened to “facing the music” (P18, M, S, 47), and even discussing 
the offer with a friend was perceived as difficult, with one partici-
pant avoiding even the word cancer, referring instead to “the big 
C” (P12, M, S, 68). Avoidance was commonly explored through the 
third person, perhaps due to social desirability, with participants 
describing instances of friends or family avoiding seeking medical 
help for lung cancer symptoms until they were unwell (see Table 4).
3.10.4 | Too late: smoking damage and older age
The perception that irreparable smoking damage had already been 
done was common and related to the belief that it is too late to pre-
vent lung cancer or change the course of their respiratory health. 
Smokers in particular discussed how the “damage is already done” 
(P3, M, S, 63) and appeared not to see screening as an opportunity to 
regain control over their risk of lung cancer mortality because “once 
you’ve smoked more than 10 years you think if I’ve got it, there’s 
nothing I can do” (P4, F, X, 58). One ex- smoker described the process 
of seeing smoking damage inside the lungs as “like going to a mortu-
ary” (P1, M, X, 54).
Tellingly, while most thought that screening should be available to 
all, some believed it would be of greatest benefit to younger adults, 
due to their shorter smoking history and ability to “withstand any 
treatment” (P23, M, X, 66). The benefit of screening for older smokers 
TABLE  3 Quotes illustrative of the general attitude themes 
(Interview Study two)
Participant
Smoking: history, stigma and identity
“I feel a bit ashamed I suppose… I don’t like to say I 
smoke… it could be a bit of guilt really”
P11, F, S, 69
“So I’m on roll- ups now… I’ve tried to give up, but I 
can’t… I’ve had advice from my doctor and 
everybody. And I still can’t… I wish I could”
P10, F, S, 63
“you don’t enjoy it you get stuck in, you don’t get 
much choice it’s addictive”
P1, M, X, 54
“when you go back 40 years ago they didn’t know 
nothing about it really, about cigarettes, the 
dangers of cigarettes, smoking and stuff”
P4, F, X, 58
“I lie to people… whatever’s wrong with you they 
say it’s down to smoking, pack it up and see ya 
later… you ain’t gonna get the proper diagnosis”
P3, M, S, 57
“I think some of these doctors and ambulance men 
now are taking it a bit personal with people… 
Because I had one doctor… the other two, it was 
like taboo. They pushed me into a corridor… I 
think they were offish in the attitude what the 
people that think the result is it’s self- inflicted”
P12, M, S, 68
“I know that the doctor would tell me off about it… 
It would be your fault, actually.”
P17, F, S, 61
“people have been smoking since Robinson 
Crusoe… It’s enjoyment for people, it’s a working 
class man’s thing… I’m no different to anybody 
else” but later adds, “if they could give me 
something to stop me smoking, I’d take it straight 
away”
P5, M, S, 56
Uncontrollable disease: risk, fatalism and treatment
“I think you’ll always be worried [about lung cancer] 
if you’ve been a heavy smoker”
P13, F, X, 66
“But I breathe heavy. I’ve got all the signs of lung 
cancer”
P10, F, S, 63
“my nan died of it, er one, two of my uncles died of 
it… so right the way back to the beginning of time 
right up until now. It’s in the genes”
P5, M, S, 56
“I worked in a car plant… everything was covered in 
powder so you were breathing that… eight hours a 
day, so that is a concern as well.”
P9, M, X, 50
“they think, “I’ll pack up smoking and live another 
ten years.” But life don’t work that way, does it?… 
when your numbers up, your numbers up”
P12, M, S, 68
“I think it’s [lung cancer] the luck of the draw isn’t it, 
really, with everything”
P11, F, S, 69
“[lung cancer] slowly suffocates you, it’s irreversible 
and they can’t do nothing for it”
P5, M, S, 56
“it will kill you for sure.. I just know that you get 
cancer and you are dead”
P16, F, X, 67
“I think it [chemotherapy] knocks them off quicker 
in some cases… I would decline it, I would just take 
my chances”
P22, F, X, 67
“with breast cancer you can have your breast off, 
but in the lungs it’s a very, I don’t know, it seems a 
different kettle of fish to me”
P11, F, S, 69
Life circumstances: poor health, life experiences and addiction
“I’ve known two or three people with it [lung 
cancer]… But the ones that I’ve known have not 
lasted that long… it’s a bit frightening”
P11, F, S, 69
Participant
“She screamed in pain until she died for more than 
a week and it’s a horrible way to go because it’s 
very painful, very nasty”
P9, M, X, 50
“Everything always turns out bad or worse for me… 
Because I’ve had a lot of negative things in my 
life… Being brought up on a council estate”
P18, M, S, 47
“I’d fix myself with booze, drinks, drugs for years” P18, M, S, 67
“I always thought I’d got lung cancer because I 
abused myself… Really badly abused myself. After 
I lost my mother and father I gave up”
P18, M, S, 47
TABLE  3  (continued)
(Continues)
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was described as relatively low, which is contradictory to the screen-
ing eligibility criteria. Related to this, some participants attributed 
their risk of lung cancer, and life expectancy more generally, to chance 
(see Table 4).
3.10.5 | Screening: approach and support
Participants emphasized the need to provide a non- judgemental 
screening service and suggested phrasing the invitation in general 
terms (i.e. in relation to an age group not smoking status), to normal-
ize the offer. Others warned mentioning smoking cessation would be 
off- putting to smokers and unnecessary, because this advice would 
be expected.
Some thought there should be interpersonal support preceding 
and during the appointment including “a family friend that could sup-
port them” (P17, F, S, 61), “a chat beforehand just to basically find 
out what… the procedure entails” (P7, F, X, 57) and “a phone number 
they could ring” (P4, F, X, 58). Others noted that the invitation wording 
should be considered carefully so as not to imply lung cancer is specif-
ically suspected (see Table 4).
4  | DISCUSSION
To our knowledge, this is the first study to explore attitudes towards 
lung cancer screening among smokers and ex- smokers from socioeco-
nomically deprived communities using proactive recruitment methods 
to engage a “hard- to- reach” sample. The majority were superficially 
supportive of screening, but interviewee accounts were often contra-
dictory, acknowledging early detection could be beneficial, but along-
side negative views of treatment and survival, especially for older 
smokers. The findings gave insight into the salience of fear, avoid-
ance, fatalism and stigma around lung cancer screening, particularly 
for smokers (as opposed to former and never smokers) which could 
deter participation.
TABLE  4 Quotes illustrative of the screening- specific attitude 
themes (Interview Study two)
Participant
Support screening: early detection, preparation, and reassurance
“a cure could be round the corner, and if you’re 
diagnosed early enough and being able to be sort 
of er put on hold… a cure might appear”
P2, M, X, 63
“what I’ve heard from TV. I mean, as far as I’m 
aware is if you catch it early enough you can 
survive… whether that’s true, I’m not too sure”
P7, F, X, 57
“I’d prefer to know, you know ‘cause you could kind 
of get your affairs in order… I’ve got a big large, 
I’ve got five children… five grandchildren”
P4, F, X, 58
“if they can do me a favour and get me some extra 
years for those grandkids… I might even be lucky 
enough to… walk them down the aisle”
P12, M, S, 68
“Oh, it would be great for me [negative result], and 
probably I would try my best not to do it, not to 
smoke”
P17, F, S, 61
“It’s like a relief; it’s something else off your 
shoulders, isn’t it… Because you carry all this 
[expletive] about with you, thinking this, thinking 
that, and it’s all negative stuff. And then you get to 
the truth [a negative result] and it’s like ah! It’s like 
a real buzz”
P18, M, S, 47
Fear: diagnosis, hospitals, getting sick and death
“I’m just frightened because I smoke a lot. I’ve been 
smoking since I was ten years of age… I think the 
shock [of a positive screen] would kill me”
P10, F, S, 63
“they’re maybe scared of hospitals, scared of 
dying… because a lot of people think, well, they go 
in with one thing and they catch all sorts”
P19, F, S, 65
“he’d just literally be too scared. He hates 
hospitals… I know he’s had bad experiences… And 
that’s his attitude: “If I go in there I won’t come out 
again”
P7, F, X, 57
Avoidance: rather not know and wait until sick
“I’d rather not know, you know, personally, and 
carry on as things are carrying on”
P12, M, S, 68
“He had a pain in his lung when he was coughing 
and he never went anywhere… and when he went 
to the doctors… he was dead within three weeks”
P5, M, S, 56
“They’d be frightened of knowing… my husband, he 
wouldn’t dream of going to a doctor… He would 
rather not know. He’d rather just, you know, one 
day he’s here, next day he’s gone… I said to him, 
“The only time you’ll see a doctor is when you’re, 
you know, halfway upstairs or downstairs”… I think 
he would have to be on death’s door before he 
actually sees the doctor”
P7, F, X, 57
Too late: smoking damage and older age
“I mean it doesn’t really bother me now, ‘cause I 
think it’s too late anyway, so I reckon the damage 
is already done anyway”
P3, M, S, 63
“Like you know in any campaign they’re running, 
yes the health benefits are great but believe me 
once you’ve smoked more than ten years you 
think if I’ve got it I’ve got it, there’s nothing I can 
do about it”
P4, F, X, 58
“I’d go now. I’d be scared to go. But I would go if I 
was younger, you know… at my age I can’t imagine 
me surviving”
P10, F, S, 63
Participant
“I would say from 25 onwards, to be honest… the 
younger, the better… they stand a chance to fight 
it. But with older people I don’t know so much… I 
think that the younger persons… their body’s 
younger, their organs are more… they are younger 
and healthier than an old person”
P22, F, X, 67
Screening: approach and support
“if they think someone is going to be there wagging 
the finger at them, that’s it, it’s out the window…”If 
you point at people and say, “Look, you’ve been 
picked out and we think you ought to be 
screened,” that will frighten them to death”
P23, M, X, 66
“it’s the way it’s worded as well because a lot of 
people sort of go “oh” and panic”
P8, M, S, 52
“Well, when you get this invitation you are thinking, 
oh I wonder if I’ve got it, that’s why they’ve sent it 
to me”
P16, F, X, 67
TABLE  4  (Continued)
(Continues)
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The level of fear of lung cancer is consistent with studies describ-
ing higher cancer fear among low SES groups.36 Fear discussed during 
the interviews most commonly concerned an expected diagnosis at 
screening due to acknowledgement that a significant smoking history 
put them at high risk. Survey data showed that this fear was substan-
tially more common among smokers. Almost three- quarters agreed 
that they often worry about their chance of getting lung cancer, com-
pared with a quarter of former and never smokers, an interestingly 
similar proportion given that former smokers are at greater risk than 
never smokers. Furthermore, a preference “not to know” was impli-
cated in smokers’ avoidance of screening by interviewees. Cancer fear 
has been shown to promote and deter screening uptake in other pro-
grammes,37 but worry about what the doctor might find is a commonly 
reported reason by smokers for delaying symptomatic presentation.38 
Therefore, emphasizing risk in screening communication could be 
counterproductive and unnecessary. Attempts to target risk percep-
tions using written information prior to screening have been unfruitful, 
with some evidence this strategy polarizes risk perceptions.39 Also, 
most smokers perceive their risk of lung cancer as higher than never 
smokers,40 with over a third we surveyed agreeing that their risk was 
higher than other smokers, and close to one- fifth thinking they may 
already have lung cancer, more than former and never smokers. In a US 
study,41 smokers’ awareness of their increased risk was not associated 
with screening interest, and in the UKLS trial, higher affective risk per-
ceptions were associated with non- participation.26 Research should 
explore the conditions under which perceived risk can motivate and 
demotivate screening attendance among smokers and unpick the con-
stituents of lung cancer fear.
To compound fear of diagnosis, smokers in particular believed 
that it was too late to benefit from screening due to irreversible 
smoking damage, despite being told the eligible age bracket. When 
interviewed, both current and former smokers described fatalistic per-
ceptions, seeing lung cancer as an uncontrollable disease for which 
treatment was ineffective and survival was poor. The survey data sug-
gested that smokers more commonly held fatalistic beliefs than their 
non- smoking counterparts: around half perceived lung cancer to be a 
death sentence. Exploration during the interviews suggested this may 
stem from vicarious experiences of suffering with lung cancer, feeling 
entrapped by tobacco addiction and a general pessimism fostered by 
poor life circumstances. Of particular note was the perception that the 
lungs are not treatable for cancer because they are a vital organ that 
cannot be removed. Indeed, over a fifth of survey participants believed 
that most treatment is actually worse than lung cancer. Negative 
views of, and low confidence in, treatment could be instrumental in 
deterring screening participation by undermining the extent to which 
early diagnosis can be perceived as beneficial. The significance of wor-
ry, avoidance and fatalism to engagement with lung cancer screen-
ing has been observed previously,27 and fatalism towards cancer has 
been associated with avoidance of early detection42 and later stage 
at diagnosis.43 Unfortunately, a poor prognosis for lung cancer is the 
most common outcome due largely to late diagnosis,3 and it will be 
difficult to overlie this with the claim for benefits of early detection. A 
lay explanation for early stage treatment may help, one that addresses 
concerns and challenges the perception that the removal of a whole 
lung is necessary for treatment to be effective. This could be achieved 
by emphasizing the targeted nature of early treatment by showing the 
lungs subdivided into lobes.
Qualitative findings also gave insight into the roles that perceived 
stigma and tobacco dependence may play. Regret, guilt and feelings 
of entrapment by smoking were commonly expressed. The stigma 
attached to lung cancer as a self- inflicted, smokers’ disease was espe-
cially apparent, which has been reported previously,44 and implicat-
ed as a deterrent to screening by a US study of long- term smokers.45 
Addiction is a disorder of motivation46 that could affect a person’s 
confidence in their ability to quit and attitudes towards screening; 
perhaps by undermining perceived benefit. Similar observations of 
perceived blame and the expectation that treatment might be denied 
have been implicated in delayed symptomatic help- seeking.47–50 Non- 
confrontational communication strategies that normalize the offer and 
reduce blame could improve engagement of more dependent smokers.
Limitations to the study design restrict our conclusions. By proac-
tively recruiting in community settings outside of health service and 
trial contexts, we achieved a sample characterized by factors predic-
tive of lower participation. However, we cannot assume the attitudes 
identified here are prevalent or generalizable beyond the English- 
speaking urban communities we accessed, and further research 
should investigate the views of minority high- risk groups. We also 
cannot infer that these attitudes differentiate lower and higher SES 
groups, because the latter were not recruited. While we report quanti-
tative results separately by smoking group, our inclusion of screening- 
ineligible adults (approaching the age threshold for eligibility and never 
smokers) may have biased our findings. In addition, it is possible that 
completing the survey primed the responses of the interviewees and 
that assisting those participants who needed help completing the 
questionnaire unintentionally biased their answers. Furthermore, the 
importance of these results for screening participation is speculative 
and large samples with representative sampling techniques and com-
prehensive measures are needed to quantify these findings. Studies 
are also needed that explore the association between these beliefs, 
screening intentions and ultimately screening behaviour. A random-
ized controlled trial51 is underway testing targeted invitation materials 
designed to improve uptake, which were informed by the results of 
this study.
In conclusion, attitudes towards lung cancer screening among 
lower SES smokers and former smokers are complex, but smokers 
appear to be the most negative when compared with former and 
never smokers. Many participants appeared to be superficially pos-
itive about screening and the benefits of early detection, but more 
detailed discussions identified feelings of loss of control of respira-
tory health and risk of lung cancer, fear and fatalism about diagnosis, 
blame and the belief that they would be unlikely to benefit person-
ally. Addiction, difficult life circumstances and negative perceptions 
of treatment appeared to exacerbate this pessimism and lack of con-
trol. The approach of lung cancer screening is distinct in targeting 
individuals based on a highly stigmatized and widely publicized risk 
behaviour, and the expectation of a diagnosis among smokers appears 
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to complicate decision- making. To achieve an equitable and effective 
lung cancer screening programme, invitation strategies need to be 
evidence- based and designed in consultation with low SES smokers to 
ensure they are sensitive to these complex attitudes.
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